[1]
I. Z. dos Santos and B. R. Ramos, “Hyperprogression after Acquisition of Resistance Mutation to Alectinib in a Patient with Lung Adenocarcinoma: Case Report”, Rev. Bras. Cancerol., vol. 71, no. 3, p. e–025098, May 2025.